Indian Biotechnology Scenario- An analysis

According to a NASSCOM-KPMG study, the R & D and biotech industry will reach a turnover of 3 billion dollars by 2010 and the bioinformatics market will reach $ 2 billion. Indian companies have become suppliers of information to customers worldwide biotech. The sequencing of genes and dissemination of genomic information for drug companies is the size of the next boom industry. India has the potential to become one of the strengths of choice in the development and manufacture of genomic medicine with a good atmosphere and well-directed research efforts and initiatives. Currently, there are about 190 biotech companies in India. The scenario in India Biotech

India is a huge market for products based on biotechnology. However, most of these products are not developed here but are imported by domestic and foreign companies. According to the analysis of capitalmarket.com, the Indian biotech industry is expected to reach Rs 4,40,000 crore in 2020.

The current demand for biotech products in India, in terms of predicting and evaluating the Information Technology Council (TIFAC) report are: - The products of fermentation-based vaccines.

- DMA products and antibiotics among healthcare products.

- Alcohol, organic acids, enzymes, amino acids, yeast and other industrial products.

There were about 400 companies in India with activities related to biotechnology in 1995. This number has increased to about 850. India and biotechnology industry is small compared to its pharmaceutical industry (about 16,000 drug makers big and small). Biotech in India started in the mid-1980s and has focused in large national or multinational drug. In 1986, the Indian government established the Department of Biotechnology (DBT), Ministry of Science and Technology. Many small biotechnology companies have been created since then.

The actors can be divided into the following companies:

- Contract Research Organizations: Sygen Labs, Biological E, Bangalore Genie, Avestha Gengraine etc.

- Biotechnology company that engages in basic research using recombinant DNA technology and develops and markets its products: like Shanta Biotech, Bharat Biotech & Biocon India.

- Wings biotech companies or subsidiaries of pharmaceutical / agro-technology, research on measurement using recombinant DNA technology: Lupin Labs, Wockhardt, RPG Life Sciences, Monsanto, Cadila Healthcare, Dr Reddy's Labs, etc.

- Companies that do not use recombinant DNA technology, but apply the principles of biotechnology: floriculture, tissue culture and society of industrial application of biotechnology industry such as enzymes, fermentation and bio-chemicals.